BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 31479941)

  • 1. Genetic and clinical characterization of congenital fibrinogen disorders in Polish patients: Identification of three novel fibrinogen gamma chain mutations.
    Wypasek E; Klukowska A; Zdziarska J; Zawilska K; Treliński J; Iwaniec T; Mital A; Pietrys D; Sydor W; Neerman-Arbez M; Undas A
    Thromb Res; 2019 Oct; 182():133-140. PubMed ID: 31479941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital afibrinogenemia: Identification and characterization of two novel homozygous fibrinogen Aα and Bβ chain mutations in two Tunisian families.
    Amri Y; Toumi Nel H; Hadj Fredj S; de Moerloose P
    Thromb Res; 2016 Jul; 143():11-6. PubMed ID: 27164460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and molecular characterization of Iranian patients with congenital fibrinogen disorders.
    Mohsenian S; Seidizadeh O; Mirakhorli M; Jazebi M; Azarkeivan A
    Transfus Apher Sci; 2021 Dec; 60(6):103203. PubMed ID: 34275736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Two Novel Fibrinogen Bβ Chain Mutations in Two Slovak Families with Quantitative Fibrinogen Disorders.
    Simurda T; Zolkova J; Snahnicanova Z; Loderer D; Skornova I; Sokol J; Hudecek J; Stasko J; Lasabova Z; Kubisz P
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation.
    Casini A; Brungs T; Lavenu-Bombled C; Vilar R; Neerman-Arbez M; de Moerloose P
    J Thromb Haemost; 2017 May; 15(5):876-888. PubMed ID: 28211264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database.
    Mohsenian S; Palla R; Menegatti M; Cairo A; Lecchi A; Casini A; Neerman-Arbez M; Asselta R; Scardo S; Siboni SM; Blatny J; Zapletal O; Schved JF; Giansily-Blaizot M; Halimeh S; Daoud MA; Platokouki H; Pergantou H; Schutgens REG; Van Haaften-Spoor M; Brons P; Laros-van Gorkom B; Van Pinxten E; Borhany M; Fatima N; Mikovic D; Saracevic M; Özdemir GN; Ay Y; Makris M; Lockley C; Mumford A; Harvey A; Austin S; Shapiro A; Williamson A; McGuinn C; Goldberg I; De Moerloose P; Peyvandi F
    Blood Adv; 2024 Mar; 8(6):1392-1404. PubMed ID: 38286442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational Epidemiology of Congenital Fibrinogen Disorders.
    Casini A; Blondon M; Tintillier V; Goodyer M; Sezgin ME; Gunes AM; Hanss M; de Moerloose P; Neerman-Arbez M
    Thromb Haemost; 2018 Nov; 118(11):1867-1874. PubMed ID: 30332696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rare heterozygous variant in FGB (Fibrinogen Merivale) causing hypofibrinogenemia in a Swedish family.
    Fager Ferrari M; Leinoe E; Rossing M; Norström E; Zetterberg E
    Blood Coagul Fibrinolysis; 2020 Oct; 31(7):481-484. PubMed ID: 32852326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital hypofibrinogenemia associated with novel homozygous fibrinogen Aα and heterozygous Bβ chain mutations.
    Castaman G; Rimoldi V; Giacomelli SH; Duga S
    Thromb Res; 2015 Jul; 136(1):144-7. PubMed ID: 25981141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital fibrinogen disorders: an update.
    de Moerloose P; Casini A; Neerman-Arbez M
    Semin Thromb Hemost; 2013 Sep; 39(6):585-95. PubMed ID: 23852822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory and Genetic Investigation of Mutations Accounting for Congenital Fibrinogen Disorders.
    Neerman-Arbez M; de Moerloose P; Casini A
    Semin Thromb Hemost; 2016 Jun; 42(4):356-65. PubMed ID: 27019463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and clinical profile of congenital fibrinogen disorders in Iran, identification of two novel mutations.
    Tavasoli B; Safa M; Dorgalaleh A; Ghasemi JB; Rezaei Makhouri F; Rezvani MR; Ahmadi A; Tabibian S; Jazebi M; Baghaipour MR; Zaker F
    Int J Lab Hematol; 2020 Oct; 42(5):619-627. PubMed ID: 32639687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of bleeding and thrombosis in inherited qualitative fibrinogen disorders.
    Castaman G; Giacomelli SH; Biasoli C; Contino L; Radossi P
    Eur J Haematol; 2019 Oct; 103(4):379-384. PubMed ID: 31314131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital fibrinogen disorder caused by digenic mutations of the
    Wang X; Tang N; Shen N; Lu Y; Li D
    Hematology; 2020 Dec; 25(1):145-148. PubMed ID: 32228225
    [No Abstract]   [Full Text] [Related]  

  • 15. Mutations in the fibrinogen aalpha gene account for the majority of cases of congenital afibrinogenemia.
    Neerman-Arbez M; de Moerloose P; Bridel C; Honsberger A; Schönbörner A; Rossier C; Peerlinck K; Claeyssens S; Di Michele D; d'Oiron R; Dreyfus M; Laubriat-Bianchin M; Dieval J; Antonarakis SE; Morris MA
    Blood; 2000 Jul; 96(1):149-52. PubMed ID: 10891444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of congenital fibrinogen disorders.
    Lebreton A; Casini A
    Ann Biol Clin (Paris); 2016 Aug; 74(4):405-12. PubMed ID: 27492693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of clinical phenotype with genetic and laboratory results in 31 patients with congenital dysfibrinogenemia in northern Slovakia.
    Simurda T; Zolkova J; Kolkova Z; Loderer D; Dobrotova M; Skornova I; Brunclíkova M; Grendar M; Lasabova Z; Stasko J; Kubisz P
    Int J Hematol; 2020 Jun; 111(6):795-802. PubMed ID: 32166693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital fibrinogen disorder with a compound heterozygote possessing two novel FGB mutations, one qualitative and the other quantitative.
    Yoda M; Kaido T; Taira C; Higuchi Y; Arai S; Okumura N
    Thromb Res; 2020 Dec; 196():152-158. PubMed ID: 32871307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of the fibrinogen gene cluster in 16 patients with congenital afibrinogenemia: novel truncating mutations in the FGA and FGG genes.
    Neerman-Arbez M; de Moerloose P; Honsberger A; Parlier G; Arnuti B; Biron C; Borg JY; Eber S; Meili E; Peter-Salonen K; Ripoll L; Vervel C; d'Oiron R; Staeger P; Antonarakis SE; Morris MA
    Hum Genet; 2001 Mar; 108(3):237-40. PubMed ID: 11354637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic analyses of novel compound heterozygous hypodysfibrinogenemia, Tsukuba I: FGG c.1129+62_65 del AATA and FGG c.1299+4 del A.
    Mukai S; Nagata K; Ikeda M; Arai S; Sugano M; Honda T; Okumura N
    Thromb Res; 2016 Dec; 148():111-117. PubMed ID: 27837696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.